Standout Papers

A review of Dengvaxia®: development to deployment 2019 2026 2021 2023 195
  1. A review of Dengvaxia®: development to deployment (2019)
    Stephen J. Thomas, In‐Kyu Yoon Human Vaccines & Immunotherapeutics
  2. Is new dengue vaccine efficacy data a relief or cause for concern? (2023)
    Stephen J. Thomas npj Vaccines

Immediate Impact

9 by Nobel laureates 35 from Science/Nature 96 standout
Sub-graph 1 of 16

Citing Papers

Dengue
2024 Standout
The immunology and immunopathology of COVID-19
2022 StandoutScience
118 intermediate papers

Works of Stephen J. Thomas being referenced

Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity
2021
Natural History of Plasma Leakage in Dengue Hemorrhagic Fever
2007
and 46 more

Author Peers

Author Last Decade Papers Cites
Stephen J. Thomas 3995 3612 698 164 5.5k
Chwan‐Chuen King 2804 2885 1040 114 5.0k
Richard G. Jarman 4650 4032 915 173 6.2k
Tadeusz J. Kochel 3285 2863 949 119 5.0k
Marc Fischer 3078 3025 1053 115 4.8k
Anthony A. Marfin 4339 4057 1180 85 6.2k
Ángel Balmaseda 3072 3084 939 107 4.6k
Isabel Rodríguez-Barraquer 2015 2291 401 86 3.7k
Aubree Gordon 2124 3048 1239 108 4.5k
Timothy P. Endy 4434 3879 460 111 5.4k
Philippe Buchy 4493 4594 2467 184 8.2k

All Works

Loading papers...

Rankless by CCL
2026